OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on September 14, 2011. The report addresses a corporate governance event regarding the transfer of the listing of the Company's Common Stock (symbol: OPK) from the NYSE Amex to the New York Stock Exchange (NYSE).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the listing transfer and does not contain financial performance data.
Material Changes
- Listing Transfer: The Board of Directors approved the transfer of the Common Stock listing from the NYSE Amex to the NYSE.
- Trading Timeline: The last day of trading on the NYSE Amex is expected to be on or about September 15, 2011. Trading on the NYSE is expected to commence on or about September 16, 2011.
- Symbol Continuity: The stock will continue to trade under the symbol "OPK" on the new exchange.
Outlook, Risks, and Management Commentary
Management has received authorization from NYSE Regulation, Inc. to effect the transfer. The Company issued a press release on September 14, 2011, announcing this change, which is included as Exhibit 99.1. The filing notes that the information in the press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. No specific risks, contingencies, or unusual items related to financial operations are disclosed in this text.
Key Facts for Investor Verification
- Confirm the exact date trading begins on the NYSE (expected September 16, 2011).
- Verify that the ticker symbol remains "OPK" post-transfer.
- Review the attached press release (Exhibit 99.1) for any additional details on the strategic rationale for the move.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.